OSE Immunotherapeutics S.A.
$3.21▼ 5.42%($-0.18)
TickerSpark Score
36/100
▌ Weak
55
Valuation
20
Profitability
10
Growth
64
Health
30
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OSE.PA research report →
52-Week Range7% of range
Low
$2.87
Current
$3.21
High
$7.70
Company Overviewwww.ose-immuno.com
About the company
Based in Nantes, France, OSE Immunotherapeutics S. A. specializes in creating immunotherapies designed to activate or regulate the immune system.
- CEO
- Marc Le Bozec
- IPO
- 2015
- Employees
- 64
- HQ
- Nantes, FR
Price Chart
-37.18% · this period
Valuation
- Market Cap
- $72.67M
- P/E
- -1.90
- P/S
- 27.75
- P/B
- 2.63
- EV/EBITDA
- -2.02
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- -1835.01%
- Net Margin
- -1439.48%
- ROE
- -96.73%
- ROIC
- -67.00%
Growth & Income
- Revenue
- $2.62M · -96.25%
- Net Income
- $-37,700,000 · -200.68%
- EPS
- $-1.69 · -198.26%
- Op Income
- $-48,059,000
- FCF YoY
- -170.57%
Performance & Tape
- 52W High
- $7.70
- 52W Low
- $2.87
- 50D MA
- $4.00
- 200D MA
- $4.72
- Beta
- 0.82
- Avg Volume
- 273.52K
Get TickerSpark's AI analysis on OSE.PA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Coverage · OSE.PA
Our OSE.PA coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on OSE.PA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OSE.PA report →Internal Compare
Similar companies
Peers in the same neighborhood.